THE PREVALENCE AND IMPACT OF HEPATIC STEATOSIS ON RESPONSE TO DAA THERAPY IN HIV-HCV COINFECTION.

被引：0
|
作者：
Johnson, Leigh P. [1 ]
Sterling, Richard K. [2 ]
机构：
[1] Virginia Commonwealth Univ, Internal Med, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1601
引用
收藏
页码：964A / 965A
页数：2
相关论文
共 50 条
  • [31] The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients
    Carrieri, Maria Patrizia
    Protopopescu, Camelia
    Marcellin, Fabienne
    Wittkop, Linda
    Lacombe, Karine
    Esterle, Laure
    Sogni, Philippe
    Salmon-Ceron, Dominique
    JOURNAL OF HEPATOLOGY, 2018, 68 (04) : 845 - 847
  • [32] Response to interferon treatment in patients with chronic hepatitis and HCV/HGV coinfection.
    Benetti, GP
    Ramella, G
    Lazza, M
    Corbellini, A
    Vitaliani, G
    Fasola, M
    Portera, G
    Ribero, ML
    Tagger, A
    HEPATOLOGY, 1997, 26 (04) : 1410 - 1410
  • [33] Quasispecies complexity and long-term outcomes in hemophiliacs with HCV/HIV coinfection.
    Sherman, KE
    Rouster, SD
    Eyster, ME
    HEPATOLOGY, 1997, 26 (04) : 1127 - 1127
  • [34] INFLUENCE OF INSULIN RESISTANCE ON HEPATIC FIBROSIS AND STEATOSIS IN HIV-HCV CO-INFECTED COMPARED TO HCV MONOINFECTED PATIENTS
    Halfon, Philippe
    Penaranda, Guillaume
    Carrat, Fabrice
    Bedossa, Pierre
    Bourliere, Marc
    Ouzan, Denis
    Renou, Christophe
    Tran, Albert
    Rosenthal, Eric
    Wartelle, Claire
    Delasalle, Patrick
    Cacoub, Patrice
    HEPATOLOGY, 2008, 48 (04) : 1143A - 1144A
  • [35] Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
    Hatu, Giorgiana
    Bailly, Francois
    Pourcelot, Emmanuel
    Pradat, Pierre
    Miailhes, Patrick
    Maynard, Marianne
    Parant, Francois
    Chiarello, Pierre
    Livrozet, Jean-Michel
    Zoulim, Fabien
    Gagnieu, Marie-Claude
    BMC INFECTIOUS DISEASES, 2014, 14
  • [36] Hepatic steatosis in HIV-HCV coinfected patients in France:: comparison with HCV monoinfected patients matched for body mass index and HCV genotype
    Castera, L.
    Loko, M. A.
    Le Bail, B.
    Coffie, P.
    De Ledinghen, V.
    Trimoulet, P.
    Winnock, M.
    Dabis, F.
    Neau, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (11-12) : 1489 - 1498
  • [37] Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
    Giorgiana Hatu
    François Bailly
    Emmanuel Pourcelot
    Pierre Pradat
    Patrick Miailhes
    Marianne Maynard
    François Parant
    Pierre Chiarello
    Jean-Michel Livrozet
    Fabien Zoulim
    Marie-Claude Gagnieu
    BMC Infectious Diseases, 14
  • [38] HCV/HIV coinfection in the DAA era: which patients have not been treated for HCV?
    Rodriguez-Monaco, F. D.
    Schwarze-Zander, C.
    Wasmuth, J-C
    Rockstroh, J. K.
    Boesecke, C.
    HIV MEDICINE, 2019, 20 : 291 - 291
  • [39] Effectiveness of Hepatitis C Virus (HCV) Antiviral Treatment in Veterans With HIV-HCV Coinfection
    Kramer, Jennifer R.
    Kanwal, Fasiha
    Mei, Minghua
    Giordano, Thomas P.
    El-Serag, Hashem
    GASTROENTEROLOGY, 2011, 140 (05) : S895 - S895
  • [40] Comparison of health related quality of life (HRQOL) in hepatitis C (HCV) infection, HIV infection and HCV/HIV coinfection.
    Fleming, C
    Christiansen, D
    Heeren, T
    Craven, DE
    Horsburgh, R
    Nunes, D
    HEPATOLOGY, 2002, 36 (04) : 559A - 559A
12345